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Abstract Tremendous advances have been made in
imaging in children with both congenital and acquired
heart disease. These include technical advances in cardiac
catheterization and conventional angiography, especially
with advancements in interventional procedures, as well as
noninvasive imaging with MR and CT angiography. With
rapid advances in multidetector CT (MDCT) technology,
most recently 64-detector array systems (64-slice MDCT),
have come a number of advantages over MR. However,
both conventional and CT angiography impart radiation
dose to children. Although the presence of radiation
exposure to children has long been recognized, it is
apparent that our ability to assess this dose, particularly in
light of the rapid advancements, has been limited.
Traditional methods of dosimetry for both conventional
and CTangiography are somewhat cumbersome or involve
a potential for substantial uncertainty. Recent develop-
ments in dosimetry, including metal oxide semiconductor
field effect transistors (MOSFET) and the availability of
anthropomorphic, tissue-equivalent phantoms have pro-
vided new opportunities for dosimetric assessments.
Recent work with this technology in state-of-the-art cardiac
angiography suites as well as with MDCT have offered
direct comparisons of doses in infants and children
undergoing diagnostic cardiac evaluation. It is with these
dose data that assessment of risks, and ultimately the
assessment of risk-benefit, can be better achieved.
Keywords ALARA . CT radiation . Cardiac
angiography . Infants and children
Introduction
There have been tremendous advances in cardiac imaging
in children during the last several decades. These include
technical advances for both noninvasive imaging, such as
multidetector array CT (MDCT) angiography [1], and
conventional angiography during heart catheterization.
These advances have accelerated recently, and are part of
the basis for this ALARA conference. Although these
advances provide a substantial diagnostic benefit, these
modalities are not without risk. Because both CT angiog-
raphy and conventional angiography require ionizing
radiation, this is also a shared risk. Although the bioeffects
of ionizing radiation include both deterministic and
stochastic effects (discussed elsewhere in this issue), the
doses used for CT angiography are well below those used
for deterministic effects. This is not the same for
conventional angiographic assessment, where skin burns
have been reported after interventional procedures [2]. The
stochastic risk is in common for these two imaging
modalities. Because of this, it is worth reviewing several
facets of the radiation issue.
Therefore, the following material (1) briefly summarizes
the rapid evolution of imaging techniques, (2) addresses
whether the issue of potential radiation-induced cancer is
still important, (3) discusses how traditional radiation
dosimetry is problematic, (4) reviews some of the current
investigations using contemporary dosimetric evaluation
for both CT and conventional angiography, and (5)
compares doses for both CTand conventional angiography.
Rapid evolution of imaging techniques
Conventional angiographic assessment during cardiac
catheterization has been around for a number of decades.
Some of the technical advances in fluoroscopy and
angiography in children are described elsewhere in this
issue (see Seibert in this issue), such as digital technology
and more recently flat-panel systems. CT has also under-
gone a remarkable development, particularly in the last few
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Durham, NC, USAyears with the availability of 64-array MDCT (64-slice
MDCT) [3]. It was not until isotropic datasets were
available that multiplanar reformats and 3-D rendering
became standard. Parallel to this, and equally important,
was an increase in data-processing and storage capability
(especially speed). These advances provided especially
unique advantages for cardiovascular assessment in
children, including improved monitoring, better global
thoracic assessment than echocardiography or MR imag-
ing, and decreased need for sedation, a byproduct of very
fast scanning [1]. In particular, given the relatively wide
effective collimation of 64-slice scanners, selective assess-
ment of cardiovascular regions in the infant (such as the
main pulmonary artery) can now be completed in less than
0.5 s. These advances with 64-slice scanners have also now
made cardiac gated examinations in both infants and
children possible (Fig. 1).
Is radiation exposure during diagnostic procedures still
an important issue?
The issue of radiation dose from CT and potential
development of cancer followed a series of articles in the
American Journal of Roentgenology [4–6]. Although this
was more than 5 years ago, the issue of potential bioeffects
of low-level radiation continues to be a topical one. For
example, the National Toxicology Program recently listed
radiation, which includes discussion of medical radiation,
as a known carcinogen [7]. Even more recently, in June
2005, the National Academy of Sciences [Biological
Effects of Ionizing Radiation (BEIR) VII Report] discussed
this issue of low-level radiation and potential cancer
development. Among comments were the following: “…
the risk of cancer proceeds in a linear fashion at lower
doses without a threshold and … the smallest dose has the
potential to cause a small increased risk to humans” [8].
Although there continues to be some debate about the risk,
if any,of low-level radiation, the fact remains that a number
of organizations continue to support the perspective of a
potential connection. Obviously, this includes the Society
for Pediatric Radiology, with this ALARA conference, but
it also involves, notably, organizations such as the Amer-
ican Academy of Pediatrics, with a clinical report on CT
and radiation [9]; the National Cancer Institute and the
Society for Interventional Radiology (SIR), with a March
2005 advisory paper on radiation risks for patients and staff
[10]; and the American College of Radiology Safety
Committee, which is developing a White Paper on
radiation risks and diagnostic imaging (David Kushner,
M.D., personal communication).
In addition, the technical advances continue to, it seems,
outpace our efforts at understanding the actual dose. This is
particularly evident with gated cardiac examinations in
children, as is discussed below.
Current dosimetry: what are the problems and solutions?
Some of the problems with MDCT include the following.
First, the technology is powerful. Diagnostically, this
provides us with rapid, high-quality examinations that
have had marked advantages in children [1, 11]. But the
word “powerful” also subsumes potentially higher radia-
Fig. 1 An infant after repair of total anomalous pulmonary venous
return. Echocardiographic assessment suggested stenosis. A gated,
reduced mA, CT angiography was performed at the level of the
confluence of the pulmonary veins. a The upper pulmonary vein has
a separate narrow (arrow) entry into the left atrium. b The remaining
three pulmonary veins are confluent but also had a stenosis (arrow)
at the entrance of the ventricle. This was due to a slight torque of the
venous confluence that developed after an anastomosis. Based on
these data, there was successful surgical correction of the stenosis
155tion doses than were seen with conventional CT and older
MDCT technology. For example, recent work with
phantoms in the setting of 64-slice MDCT has shown
that doses in the range of 50 mSv to nearly 120 mSv can
be generated by maximizing those settings that provide
radiation dose in children (Donald Frush, M.D., unpub-
lished data). There is no provision (either from a
regulatory standpoint or a manufacturer standpoint) that
prevents this from occurring. Simply stated, the radiology
community and manufacturers, as well as regulatory
agencies, need to work toward a regulatory component of
CT, such as warning indicators for certain high radiation
dose examinations.
One other problem with MDCT is that the scientific
community is lagging in terms of providing data on CTuse.
This includes outcomes for the newer MDCT as well as
technical parameters for optimizing examination. These
data lag behind both marketing pressures to sell the newest
CT scanner and public perceptions and demands of the
benefits of these types of scanners. This has been seen with
screening examinations as well as gated cardiac CTstudies
in adults. The presumed validation of gated examinations
in cardiac screening was recently promulgated by Oprah
Winfrey [12]. Although the outcome of this sort of
promotion has not been scientifically rigorously tested,
the influence on public opinion by such spokespersons and
subsequent provocative trends in use are, in general,
recognized.
In addition, and perhaps most important, dose data for
both the newer MDCTexaminations and the contemporary
angiographic equipment are lacking. This is multifactorial
but in large part a result of the fact that previous methods of
dosimetric assessment have been cumbersome. For exam-
ple, surface assessment such as dose area product (DAP)
does not provide organ dose and effective dose equivalent
data for determination of risks. Traditional thermolumi-
nescence dosimetry techniques are essentially single-
exposure and take a great deal of effort to load into (and
remove from) the phantoms, including anthropomorphic
phantoms. Essentially, they are a single-exposure device
during a CT or angiographic examination. For a CT
examination, the CT dose index (CTDI) and resultant dose
length product (DLP) displayed on the console are
problematic for MDCT [13, 14], and in general will
misrepresent the true dose to the patient. In addition, the
conversion factors used with the DLP to estimate the
Fig. 2 Anthropomorphic phantom. a Posterior view of the 1-year-old anthropomorphic phantom. b Corresponding slices contain holes for
dosimetric devices, including MOSFET detectors, representing organs
156effective dose might not reflect the dose resulting from
current CT technology. Other methods of dosimetric
assessment such as those using Monte Carlo codes might
have not been validated using contemporary CT equip-
ment. What is needed, then, is an accurate and simple
dosimetric technology. This would allow more versatile
assessment of current cardiac imaging modalities and allow
for dose comparisons. This, then, would help in establish-
ing the risk–benefit balance.
During the last few years we have been testing,
validating, and applying some of this new dosimetric
technology. This includes tissue-specific pediatric anthro-
pomorphic phantoms (CIRS, Norfolk, Va.) (Fig. 2), as well
as metal oxide semiconductor field effect transistor
(MOSFET) technology (Thomson-Nielson, Ottawa, Can-
ada). Briefly, organ doses supplied by MOSFET technol-
ogy can be used to determine an effective dose equivalent
for both CT angiography and cardiac angiography.
The first stage in the use of this combination of
dosimetry tools was validation. This was carried out
using traditional TLD dosimetry and Monte Carlo model-
ing. In adult CT examinations, MOSFET technology was
found to be accurate and reliable compared with these other
two more conventional techniques during chest and
abdomen MDCT examinations. The advantage of the
MOSFET technology is that this is a real-time assessment.
Data are automatically transmitted to a laptop computer.
Multiple CT examinations (or angiographic “runs”) can be
obtained in a single session, a great advantage compared
with essentially single examination TLD technology.
After this validation was completed, we evaluated the
MOSFET dosimetry and phantom model with CT dosim-
etry estimation, namely the DLP estimation. The DLP is
derived from the CTDI available on scanner consoles.
Using a conversion factor, the DLP estimates the dose for
the MDCT parameters selected. Again, this dose does not
have anything to do with the individual patient but is
derived from an acrylic phantom (two sizes only) exposed
using the individual settings. As mentioned before, we
have found that this DLP method is relatively inaccurate in
providing doses. For example, in a series of comparisons
between MOSFET technology and the DLP method in
adult chest and abdomen scanning, there was up to 50%
greater effective dose measured by MOSFET technology
than estimated by the DLP method (Lynne Hurwitz,
Durham, N.C., unpublished data).
In summary, current technology provides new opportu-
nities for dosimetric assessment in diagnostic imaging. In
particular, comparison of the effective dose for pediatric
cardiac angiography and CT angiography is now possible.
Dose comparisons for MDCT and conventional
angiography in children
This is divided into three sections: CT angiography, gated
CT angiography, and conventional angiography. Much of
what is discussed here has been information recently
presented at national meetings or in the press. Summary
data for this material are provided.
First, MOSFET and anthropomorphic phantoms in
combination were used to determine the effective dose
for conventional CTangiography in both a 1- and a 5-year-
old. This was performed on a 16-slice scanner (GE
Healthcare, Milwaukee, Wis.). Doses using 80 kVp,
100 kVp, and 120 kVp ranged from just more than
1.0 mSv to 2.5 mSv in the 5-year old. For a 1-year-old,
these doses were from about 1.5 mSv to 4.0 mSv (Fig. 3).
These doses are in the range of those used for conventional
(nonangiographic) chest CT in children.
A gated cardiac CT provides additional challenges in
children. The nature of this examination, traditionally with
relatively high tube current and very low pitch, makes it a
potentially very high-dose examination. Despite this fact,
excellent anatomic information can be obtained and can
obviate cardiac catheterization and associated risks. Data
regarding doses for pediatric gated cardiac CT, however,
are limited. In our laboratory we have found that the adult
dose range is approximately 11 mSv to more than 20–
25 mSv; however, published data in children are lacking.
We looked at gated cardiac CT in children and found,
depending on the setting used, that doses could range just
over 7.0 mSv to more than 25 mSv (Caroline Hollings-
worth, Durham, N.C., unpublished data). Although image
quality in these phantom studies was not assessed, our
experience has been that acceptable image quality can be
obtained with examinations performed at the lower end of
these doses (Fig. 1). With that said, it is reasonable to
conclude that gated cardiac CT examinations will provide
doses that are probably multiples of nongated CT
angiographic effective dose equivalents in children.
How do these doses compare with conventional angi-
ography? In the literature, a number of investigations have
provided dose ranges for pediatric procedures [15–21]. The
range is obviously wide, and varies from approximately
5.0 mSv to more than 20 mSv, for complex interventional
procedures. Again, the methodology used includes the
DAP, Monte Carlo codes, and thermoluminescence do-
simetry. These are, as noted previously, problematic. We
have been able to use the same MOSFET and phantom
technology in the pediatric catheterization laboratory in an
effort to determine more reliable doses (Fig. 4).
Fig. 3 Data from 16-slice MDCT angiography show the effective
dose equivalents determined from organ dose measurements in an
anthropomorphic phantom for routine (nongated) angiographic
assessment at three kilovoltages
157In summary, the dose will depend on a number of
factors, most obviously fluoroscopic time, and projection,
use of fluoroscopy vs. cine angiography, and age and size
of patient. Although it would have been possible to recreate
an individual catheterization procedure, we found it more
versatile to develop a dose calculator based on a dose rate
(per second) depending on the projection for both cine and
fluoroscopy. We found in the 1-year-old and 5-year-old that
we were able to calculate effective dose equivalent for
procedures. This applied to both prospective assessment
for a procedure where the length of fluoroscopic and cine
evaluation for the various projections could be estimated.
In addition, this calculator allowed one to go back and
determine a dose estimate knowing this information on a
procedure that had already been performed. In general, CT
angiographic (nongated) dosimetry was below conven-
tional angiographic assessment (diagnostic only) for
routine evaluation of structures such as the aorta for
coarctation, or pulmonary arteries for pulmonary arteries
stenosis. Again, the dose delivered will vary depending on
the individual patient needs, and the physician performing
the examination. Be that as it may, the calculator and the
information provided from our dosimetry from MDCT
offered a more versatile and accurate tool for assessment of
the relative doses (for the 1- and 5-year-old children) and
determination of potential risks of these procedures.
Conclusion
There has been a rapid evolution of imaging techniques.
The traditional methods of dosimetry have substantial
limitations for assessing radiation dose from evolving
cardiac imaging modalities consisting of conventional
angiography and CT angiography. However, use of
MOSFET technology together with a set of pediatric
anthropomorphic phantoms has resulted in an accurate and
simple, extremely versatile method for radiation dose
determination. In particular, this allowed us to better
estimate doses for pediatric cardiac imaging during MDCT
and conventional angiography. From these dosimetry tools,
the effect of techniques such as decreasing tube current for
gated CT examinations in small children will likely ensue,
in the spirit of the ALARA principle.
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